AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| ITL | Notice of Annual General Meeting/Proxy Form | 23/04/18 | ||
| ITL | Application to Delist from ASX | PRICE SENSITIVE | 12/04/18 | |
| ITL | Release of 2017 Audited Financial Results | 03/04/18 | ||
| ITL | Appendix 4G | 03/04/18 | ||
| ITL | Annual Report to shareholders | 03/04/18 | ||
| ITL | Sales Distribution Agreements | PRICE SENSITIVE | 19/03/18 | |
| ITL | Update on Proposed Share Swap Transaction | 01/03/18 | ||
| ITL | Preliminary Final Report | PRICE SENSITIVE | 01/03/18 | |
| ITL Notice of Annual General Meeting/Proxy Form | |||
| 23/04/18 | |||
| ITL Application to Delist from ASX | |||
| 12/04/18 | PRICE SENSITIVE | ||
| ITL Release of 2017 Audited Financial Results | |||
| 03/04/18 | |||
| ITL Appendix 4G | |||
| 03/04/18 | |||
| ITL Annual Report to shareholders | |||
| 03/04/18 | |||
| ITL Sales Distribution Agreements | |||
| 19/03/18 | PRICE SENSITIVE | ||
| ITL Update on Proposed Share Swap Transaction | |||
| 01/03/18 | |||
| ITL Preliminary Final Report | |||
| 01/03/18 | PRICE SENSITIVE | ||
